Related Experiment Video
Updated: Jun 2, 2026
07:20
Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
Published on: August 9, 2024
A pulse rapamycin therapy for infantile spasms and associated cognitive decline
Emmanuel Raffo1, Antonietta Coppola, Tomonori Ono
1Saul R. Korey Department of Neurology, Albert Einstein College of Medicine, Bronx NY 10461, USA.
Neurobiology of Disease
|April 21, 2011
Summary
Rapamycin, a TORC1 inhibitor, effectively treats infantile spasms and improves cognitive function in a rat model. This promising therapy shows disease-modifying potential for infantile spasms, even those resistant to standard treatments.
Area of Science:
- Neuroscience
- Pharmacology
- Developmental Biology
Background:
- Infantile spasms are severe epileptic encephalopathies causing cognitive impairment.
- Current therapies like ACTH and steroids have limited efficacy and side effects.
- TORC1 pathway overactivation is implicated in some infantile spasms, such as those in tuberous sclerosis.
Purpose of the Study:
- To investigate rapamycin, a TORC1 inhibitor, as a treatment for infantile spasms.
- To evaluate rapamycin's effects in a rat model of ACTH-refractory infantile spasms not linked to tuberous sclerosis.
- To assess rapamycin's impact on spasms, other seizures, cognitive function, and TORC1 pathway activity.
Main Methods:
- Administered rapamycin or vehicle to rats after spasm onset.
- Assessed spasm frequency, other seizure types, and visuospatial learning (Barnes maze).
- Quantified phosphorylated S6 ribosomal protein (pS6) expression in the cortex via immunofluorescence.
Main Results:
- Rapamycin dose-dependently suppressed infantile spasms and improved visuospatial learning.
- High-dose pulse rapamycin achieved sustained spasm suppression and cognitive improvement with no significant side effects.
- Effective rapamycin doses normalized elevated cortical pS6 levels in affected pups.
Conclusions:
- Pathological TORC1 overactivation contributes to infantile spasms, including non-tuberous sclerosis-associated forms.
- High-dose, pulse rapamycin is a well-tolerated, disease-modifying therapy for infantile spasms.
- Rapamycin offers a promising new treatment option for ACTH-refractory infantile spasms.
